TFPI and coronary artery disorder: This may explain occasional “paradoxical” outcomes as prolonged lag time or reduced ETP and peak height [3] in patients in the acute phase of coronary artery disease, where counteracting forces (including TFPI) may delay but not impair thrombin generation in plasma.